Due to rise in cardiovascular disease throughout the world, there is increasing demand for small diameter blood vessels as replacement grafts. In principle, the need for large number of autologous cells to populate those tissues can be met by adult mesenchymal stem cells (MSC), which show significant proliferation and differentiation potential. However, reports from several laboratories including ours showed that MSC originating from older donors suffer from limited proliferative capacity and significantly reduced differentiation potential. This is a major concern, as the patients mostly in need for vascular grafts are elderly. The current proposal seeks to address this challenge using a highly innovative approach that is based on preliminary data from our laboratory showing that the effects of aging can be reversed by expression of a single transcription factor, namely Nanog. Based on these results we propose the following specific aims. In the new aim 1 we will examine whether transient expression of Nanog is sufficient to reverse the effects of donor aging on proliferation and myogenic differentiation of MSC.
In aim 2 we will investigate a novel hypothesis to uncover the mechanism through which Nanog enhances transcription of myogenic genes and contractile function. We will also employ oligonucleotide microarrays as well as high throughput epigenetic analysis to determine how Nanog restructures the chromatin and unravel novel genes that are differentially expressed due to Nanog expression.
In aim 3 we will develop a novel strategy to deliver the Nanog protein into MSC in order to restore their lost function. Novel hypotheses will be addressed to engineer Nanog protein variants with enhanced transcriptional activity in order to maximize their potency in reversing the effects of senescence on MSC myogenic differentiation potential. Finally, in aim 4 we will examine the potential of the Nanog-treated stem cells for engineering small-diameter, functional blood vessels that could be implanted into the arterial system of a pre-clinical ovine animal model that was developed in our laboratory. Successful completion of this project will significantly enhance the therapeutic clinical potential of MSC from adult donors without genetic modification or reprogramming to the pluripotent state.

Public Health Relevance

Mesenchymal stem cells have tremendous potential as cell source for cellular therapies for treatment of cardiovascular disease. However, the proliferation and differentiation potential of MSC declines significantly with donor age, limiting the potential f MSC for treatment of older patients, the population most likely to suffer from cardiovascular disease. Here we propose a highly innovative research plan to reverse the effects of aging and enhance the therapeutic potential of MSC.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL086582-05A1
Application #
8629183
Study Section
Bioengineering, Technology and Surgical Sciences Study Section (BTSS)
Program Officer
Lundberg, Martha
Project Start
2006-12-01
Project End
2017-11-30
Budget Start
2013-12-16
Budget End
2014-11-30
Support Year
5
Fiscal Year
2014
Total Cost
$343,126
Indirect Cost
$118,126
Name
State University of New York at Buffalo
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
038633251
City
Buffalo
State
NY
Country
United States
Zip Code
14260
Alimperti, Stella; You, Hui; George, Teresa et al. (2014) Cadherin-11 regulates both mesenchymal stem cell differentiation into smooth muscle cells and the development of contractile function in vivo. J Cell Sci 127:2627-38
Coulombe, Kareen L K; Bajpai, Vivek K; Andreadis, Stelios T et al. (2014) Heart regeneration with engineered myocardial tissue. Annu Rev Biomed Eng 16:1-28
Swartz, Daniel D; Andreadis, Stelios T (2013) Animal models for vascular tissue-engineering. Curr Opin Biotechnol 24:916-25
Mistriotis, Panagiotis; Andreadis, Stelios T (2013) Hair follicle: a novel source of multipotent stem cells for tissue engineering and regenerative medicine. Tissue Eng Part B Rev 19:265-78
Liang, Mao-Shih; Koobatian, Maxwell; Lei, Pedro et al. (2013) Differential and synergistic effects of mechanical stimulation and growth factor presentation on vascular wall function. Biomaterials 34:7281-91
Andreadis, Stelios T (2013) Give your heart a chance: match the muscle to the vessel. Cardiovasc Res 98:1-2
Bajpai, Vivek K; Mistriotis, Panagiotis; Andreadis, Stelios T (2012) Clonal multipotency and effect of long-term in vitro expansion on differentiation potential of human hair follicle derived mesenchymal stem cells. Stem Cell Res 8:74-84
Peng, Haofan; Schlaich, Evan M; Row, Sindhu et al. (2012) A novel ovine ex vivo arteriovenous shunt model to test vascular implantability. Cells Tissues Organs 195:108-21
Peng, Hao-Fan; Liu, Jin Yu; Andreadis, Stelios T et al. (2011) Hair follicle-derived smooth muscle cells and small intestinal submucosa for engineering mechanically robust and vasoreactive vascular media. Tissue Eng Part A 17:981-90
Liang, Mao-Shih; Andreadis, Stelios T (2011) Engineering fibrin-binding TGF-?1 for sustained signaling and contractile function of MSC based vascular constructs. Biomaterials 32:8684-93

Showing the most recent 10 out of 13 publications